Literature DB >> 22184489

Assessment and management of febrile neutropenia in emergency departments within a regional health authority-a benchmark analysis.

D Szwajcer1, P Czaykowski, D Turner.   

Abstract

OBJECTIVES: Febrile neutropenia is considered an oncologic emergency, for which prompt initiation of antibiotics is essential.
METHODS: We conducted a retrospective cohort study for the 2006 calendar year involving all adult oncology patients presenting with febrile neutropenia to a regional health authority's emergency departments. The objective was to determine the time from triage to antibiotic administration and its impact on patient outcomes.
RESULTS: We identified 68 patients presenting with febrile neutropenia, most of whom (76%) were seen in tertiary care centers. Of those patients, 65% were triaged to be seen within 15 minutes of arrival in the emergency room; however, the median time to reassessment was 57 minutes. The median time from triage to antibiotic administration was 5 hours (range: 1.23-22.8 hours). No increased risk of death or increased length of hospital stay was associated with delayed antibiotic administration. Older patients and patients without caregiver support were more likely to experience delayed antibiotic administration (odds ratio: 3.8 and 12.7 respectively).
CONCLUSIONS: We were not able to show a deleterious effect of delay in antibiotic administration, but our analysis identified several points at which patient flow through the emergency room could be improved.

Entities:  

Keywords:  Antineoplastic chemotherapy; emergency department; febrile neutropenia

Year:  2011        PMID: 22184489      PMCID: PMC3224029          DOI: 10.3747/co.v18i6.841

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  16 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections.

Authors:  S Natsch; B J Kullberg; J W van der Meer; J F Meis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-10       Impact factor: 3.267

3.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

4.  Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality.

Authors:  Elizabeth H Bradley; Jeph Herrin; Brian Elbel; Robert L McNamara; David J Magid; Brahmajee K Nallamothu; Yongfei Wang; Sharon-Lise T Normand; John A Spertus; Harlan M Krumholz
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

5.  Neutropenic fever: one institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy.

Authors:  Tammy Baltic; Evelyn Schlosser; Marilyn Kay Bedell
Journal:  Clin J Oncol Nurs       Date:  2002 Nov-Dec       Impact factor: 1.027

6.  The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Authors:  J Klastersky; M Paesmans; E B Rubenstein; M Boyer; L Elting; R Feld; J Gallagher; J Herrstedt; B Rapoport; K Rolston; J Talcott
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

7.  Risk factors for Gram-negative bacterial infections in febrile neutropenia.

Authors:  Catherine Cordonnier; Raoul Herbrecht; Agnès Buzyn; Guy Leverger; Roland Leclercq; Gérard Nitenberg; Sylvie Bastuji-Garin
Journal:  Haematologica       Date:  2005-08       Impact factor: 9.941

8.  Management of fever in neutropenic patients with different risks of complications.

Authors:  Jean Klastersky
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

9.  Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).

Authors:  C Viscoli; P Bruzzi; E Castagnola; L Boni; T Calandra; H Gaya; F Meunier; R Feld; S Zinner; J Klastersky
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

10.  A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.

Authors:  Jorge Sierra; Jeffrey Szer; Jeannine Kassis; Richard Herrmann; Mario Lazzarino; Xavier Thomas; Stephen J Noga; Nigel Baker; Roger Dansey; Alberto Bosi
Journal:  BMC Cancer       Date:  2008-07-10       Impact factor: 4.430

View more
  10 in total

1.  Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.

Authors:  Lisa M Daniels; Urshila Durani; Jason N Barreto; John C O'Horo; Mustaqeem A Siddiqui; John G Park; Pritish K Tosh
Journal:  Support Care Cancer       Date:  2019-02-25       Impact factor: 3.603

2.  Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.

Authors:  Byuk Sung Ko; Shin Ahn; Yoon-Seon Lee; Won Young Kim; Kyung Soo Lim; Jae-Lyun Lee
Journal:  Support Care Cancer       Date:  2015-02-10       Impact factor: 3.603

3.  The Emergency Care of Patients With Cancer: Setting the Research Agenda.

Authors:  Jeremy Brown; Corita Grudzen; Demetrios N Kyriacou; Ziad Obermeyer; Tammie Quest; Donna Rivera; Susan Stone; Jason Wright; Nonniekaye Shelburne
Journal:  Ann Emerg Med       Date:  2016-02-26       Impact factor: 5.721

4.  Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department With Fever and Neutropenia: Efficacy and Barriers.

Authors:  Clay Cohen; Amber King; Chee Paul Lin; Gregory K Friedman; Kathy Monroe; Matthew Kutny
Journal:  Pediatr Emerg Care       Date:  2016-11       Impact factor: 1.454

5.  A nurse-led protocol improves the time to first dose intravenous antibiotics in septic patients post chemotherapy.

Authors:  Graeme Mattison; Matthew Bilney; Phil Haji-Michael; Tim Cooksley
Journal:  Support Care Cancer       Date:  2016-07-25       Impact factor: 3.603

6.  Improving hospital performance in the treatment of febrile neutropenia.

Authors:  Barry Meisenberg; Jan Clemons; John Ness; Nancy Faust; Mary Clance
Journal:  Support Care Cancer       Date:  2014-08-09       Impact factor: 3.603

7.  Time to antibiotic administration in children with febrile neutropenia: Report from a low middle-income country.

Authors:  Namrata Todurkar; Amita Trehan; Deepak Bansal
Journal:  Indian J Med Res       Date:  2021-04       Impact factor: 5.274

8.  Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs.

Authors:  Jennifer L Salstrom; Rebecca L Coughlin; Kathleen Pool; Melissa Bojan; Camille Mediavilla; William Schwent; Michael Rannie; Dawn Law; Michelle Finnerty; Joanne Hilden
Journal:  Pediatr Blood Cancer       Date:  2015-02-07       Impact factor: 3.167

9.  Time to antibiotics and outcomes in cancer patients with febrile neutropenia.

Authors:  Thomas Perron; Mohamed Emara; Shahid Ahmed
Journal:  BMC Health Serv Res       Date:  2014-04-10       Impact factor: 2.655

10.  Patterns of Bacterial Isolates and their Resistance to Antibiotics in Patients with Chemotherapy-induced Febrile Neutropenia at a University Hospital.

Authors:  Said Ahmed Al Saifi; Badriya Al Adawi; Ikram Burney
Journal:  Oman Med J       Date:  2021-07-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.